查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1421807

关节疼痛注射市场、份额、规模、趋势、行业分析报告：按产品、按关节类型、按分销管道、按地区、按细分市场、预测，2023-2032年

Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product ; By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research最新研究显示，到2032年，全球关节止痛注射剂市场规模预计将达到123.6亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

这是扩大关节疼痛注射适应症的绝佳机会。 目前，这些注射剂用于治疗骨关节炎和相关疾病。 然而，研发工作正在探索可能涵盖更广泛的关节疾病的新适应症，例如肌腱炎、滑囊炎和其他肌肉骨骼疾病。

含有富血小板血浆 (PRP) 的生物关节疼痛注射剂、干细胞疗法和透明质酸衍生物的开发和使用带来了显着的增长机会。 生物注射具有再生潜力，可以促进组织修復和癒合。 将生物製剂引入关节疼痛注射市场带来了先进和整体的治疗选择，特别是对于寻求关节疾病再生解决方案的患者。

个人化医疗正在各个医疗保健领域引起关注。 根据每位患者的特定关节状况、病史和遗传因素，为其量身订做关节疼痛注射剂，可以大大改善治疗结果。 透过客製化药物选择、剂量和治疗计划，医疗保健提供者可以优化关节疼痛注射的有效性，并为患者提供先进的疼痛管理解决方案。

在后新冠时代，远距医疗和虚拟医疗就诊已被广泛采用。 患者越来越愿意远距咨询关节疼痛问题，医疗保健提供者正在利用远距医疗来评估、诊断关节疼痛并开出注射药物。 这种整合提供了便利，减少了亲自就诊的需要，与疫情导致的患者偏好的变化一致。

患者体验变得越来越重要。 医疗保健提供者致力于创建一个以患者为中心的环境，以培养信任和满意度。 这种方法包括加强沟通、个人化护理计划以及为寻求关节疼痛注射的患者提供全面支持。

关节痛注射剂市场报告亮点

由于对缓解疼痛和改善关节的非手术选择的需求不断增加，透明质酸注射已成为最大的细分市场。

由于膝关节相关疾病的高盛行率、对微创治疗的偏好以及患者意识的提高，膝关节已成为最大的部位

主要是由于消费者需求、便利性、可访问性以及与电子商务的融合不断增长。

由于人口老化、骨关节炎等关节相关疾病的盛行率上升以及对非手术治疗方案的需求不断增长，北美地区在 2022 年占据了大部分市场份额。

目录

第 1 章简介

第 2 章执行摘要

第 3 章研究方法

第 4 章全球关节止痛注射市场洞察

  • 关节止痛注射市场 - 关节类型概况
  • 麻痹注射液市场动态
    • 促进因素和机会
      • 人口老化、关节疾病流行、对微创治疗的需求不断增加
      • 生物技术与创新配方的进步
    • 抑制因素和挑战
      • 严格的监管审批和合规挑战
  • PESTEL 分析
  • 关节痛注射剂市场关节类型趋势
  • 价值链分析
  • COVID-19 感染的影响分析

第 5 章全球关节疼痛注射市场，依产品

  • 主要发现
  • 简介
  • 皮质类固醇注射液
  • 玻尿酸注射液
  • 多血小板血浆注射
  • 干细胞注射
  • 其他

第 6 章全球关节疼痛注射剂市场（依通路）

  • 主要发现
  • 简介
  • 零售药局
  • 医院药房
  • 网路药局

第 7 章全球关节疼痛注射市场，依关节类型划分

  • 主要发现
  • 简介
  • 臀部
  • 膝盖
  • 肩膀和肘部
  • 手和手腕
  • 其他

第 8 章全球关节疼痛注射市场（按地区）

  • 主要发现
  • 简介
    • 2019-2032 年关节痛注射剂市场评估（按地区）
  • 关节痛注射市场 - 北美
    • 北美：关节止痛注射市场，按产品，2019-2032 年
    • 北美：关节止痛注射市场，依关节型，2019-2032 年
    • 北美：关节止痛注射市场，依通路划分，2019-2032 年
    • 关节痛注射剂市场 - 美国
    • 关节疼痛注射市场 - 加拿大
  • 关节痛注射市场 - 欧洲
    • 欧洲：关节止痛注射市场，依产品分类，2019-2032 年
    • 欧洲：关节止痛注射剂市场，以关节类型，2019-2032 年
    • 欧洲：关节止痛注射市场，依通路划分，2019-2032 年
    • 关节痛注射剂市场 - 英国
    • 关节痛注射剂市场 - 法国
    • 关节疼痛注射剂市场 - 德国
    • 关节痛注射剂市场 - 义大利
    • 关节疼痛注射市场 - 西班牙
    • 关节疼痛注射剂市场 - 荷兰
    • 关节疼痛注射市场 - 俄罗斯
  • 关节痛注射市场 - 亚太地区
    • 亚太地区：关节止痛注射市场，按产品，2019-2032 年
    • 亚太地区：关节止痛注射市场，依关节类型，2019-2032 年
    • 亚太地区：关节止痛注射市场，依通路划分，2019-2032 年
    • 麻痹注射市场 - 中国
    • 关节痛注射剂市场 - 印度
    • 关节疼痛注射市场 - 马来西亚
    • 麻痹注射剂市场－日本
    • 关节痛注射剂市场－印度尼西亚
    • 麻痹注射剂市场－韩国
  • 关节疼痛注射剂市场 - 中东和非洲
    • 中东和非洲：关节止痛注射市场，按产品，2019-2032 年
    • 中东和非洲：关节止痛注射市场，按关节类型，2019-2032 年
    • 中东和非洲：关节止痛注射市场，依通路划分，2019-2032 年
    • 关节痛注射剂市场－沙乌地阿拉伯
    • 关节痛注射剂市场 - 阿拉伯联合大公国
    • 关节痛注射剂市场 - 以色列
    • 关节疼痛注射剂市场 - 南非
  • 关节痛注射剂市场－拉丁美洲
    • 拉丁美洲：关节止痛注射市场，按产品，2019-2032 年
    • 拉丁美洲：关节止痛注射市场，依关节类型，2019-2032 年
    • 拉丁美洲：关节止痛注射市场，依通路划分，2019-2032 年
    • 关节疼痛注射剂市场 - 墨西哥
    • 关节疼痛注射剂市场 - 巴西
    • 麻痹注射液市场－阿根廷

第 9 章竞争态势

  • 扩张与收购分析
    • 扩大
    • 收购
  • 伙伴关係/协作/协议/揭露

第 10 章公司简介

  • AbbVie Inc
  • Alkem Laboratories
  • Anika Therapeutics
  • Bioventus
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • GlaxoSmithKline（GSK）
  • Johnson & Johnson
  • Merck
  • Pacira BioSciences, Inc.
  • Pfizer
  • Sanofi
  • Seikagaku Corporation
  • Teva Pharmaceuticals
  • Zimmer Biomet
Product Code: PM4129

The global joint pain injections market size is expected to reach USD 12.36 billion by 2032, according to a new study by Polaris Market Research. The report "Joint Pain Injections Market Share, Size, Trends, Industry Analysis Report, By Product (Corticosteroid Injections, Hyaluronic Acid Injections, Platelet-Rich Plasma Injections, Stem Cell Injections, Others); By Joint Type; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

There is a significant opportunity to expand the indications for joint pain injections. Currently, these injections are used for osteoarthritis and related conditions. However, research and development efforts are exploring new indications, potentially covering a broader range of joint conditions, such as tendinitis, bursitis, and other musculoskeletal disorders.

The development and use of biologic joint pain injections, including platelet-rich plasma (PRP), stem cell therapies, and hyaluronic acid derivatives, present a notable growth opportunity. Biologic injections have regenerative potential and can stimulate tissue repair and healing. Incorporating biologics into the joint pain injection market introduces advanced and holistic treatment options, particularly for patients seeking regenerative solutions for their joint conditions.

Personalized medicine is gaining prominence across various healthcare sectors. Tailoring joint pain injections to individual patients based on their specific joint condition, medical history, and genetic factors significantly enhances treatment outcomes. By customizing the choice of medication, dosage, and treatment plan, healthcare providers optimize the effectiveness of joint pain injections and deliver highly tailored pain management solutions to patients.

The adoption of telemedicine and virtual healthcare consultations has become more widespread in the post-COVID era. Patients are increasingly open to discussing joint pain issues remotely, and healthcare providers are leveraging telemedicine to evaluate, diagnose, and prescribe joint pain injections. This integration offers convenience and reduces the need for in-person visits, which aligns with pandemic-induced changes in patient preferences.

The patient experience has gained significance. Healthcare providers are focusing on creating a patient-centered environment that fosters trust and satisfaction. This approach includes enhanced communication, personalized care plans, and comprehensive support for individuals seeking joint pain injections.

Joint Pain Injections Market Report Highlights

Hyaluronic acid injections emerged as the largest segment on account of greater demand for non-surgical alternatives for pain relief and joint improvement

Knee emerged as the largest segment on account of higher incidence of knee-related conditions, preference towards less invasive treatments, and increased patient awareness

Retail pharmacies held the maximum market revenue share in 2022, mainly due to growing consumer demand, convenience, easy access, and e-commerce integration

North America region dominated the market with a majority share in 2022, owing to an aging population, rising prevalence of joint-related conditions like osteoarthritis, and growing demand for non-surgical treatment options

The global key market players include: Anika Therapeutics, Bioventus, Eli Lilly and Company, Ferring Pharmaceuticals, and Pacira BioSciences, Inc., among others

Polaris Market Research has segmented the Joint Pain Injections market report based on product, joint type, distribution channel, and region:

Joint Pain Injections, Product Outlook (Revenue - USD Billion, 2019 - 2032)

  • Corticosteroid Injections
  • Hyaluronic Acid Injections
  • Platelet-Rich Plasma Injections
  • Stem Cell Injections
  • Others

Joint Pain Injections, Joint Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hip
  • Knee
  • Shoulder and Elbow
  • Hand and Wrist
  • Others

Joint Pain Injections, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

Joint Pain Injections, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Joint Pain Injections Market Insights

  • 4.1. Joint Pain Injections Market - Joint Type Snapshot
  • 4.2. Joint Pain Injections Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Aging population, prevalence of joint disorders, and rise in demand for minimally invasive treatments
      • 4.2.1.2. Advancements in biotechnology and innovative formulations
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Stringent regulatory approvals and compliance challenges
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Joint Pain Injections Market Joint Type Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Joint Pain Injections Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • 5.3. Corticosteroid Injections
    • 5.3.1. Global Joint Pain Injections Market, by Corticosteroid Injections, by Region, 2019-2032 (USD Billion)
  • 5.4. Hyaluronic Acid Injections
    • 5.4.1. Global Joint Pain Injections Market, by Hyaluronic Acid Injections, by Region, 2019-2032 (USD Billion)
  • 5.5. Platelet-Rich Plasma Injections
    • 5.5.1. Global Joint Pain Injections Market, by Platelet-Rich Plasma Injections, by Region, 2019-2032 (USD Billion)
  • 5.6. Stem Cell Injections
    • 5.6.1. Global Joint Pain Injections Market, by Stem Cell Injections, by Region, 2019-2032 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Joint Pain Injections Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Joint Pain Injections Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 6.3. Retail Pharmacies
    • 6.3.1. Global Joint Pain Injections Market, by Retail Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.4. Hospital Pharmacies
    • 6.4.1. Global Joint Pain Injections Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 6.5. Online Pharmacies
    • 6.5.1. Global Joint Pain Injections Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

7. Global Joint Pain Injections Market, by Joint Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • 7.3. Hip
    • 7.3.1. Global Joint Pain Injections Market, by Hip, By Region, 2019-2032 (USD Billion)
  • 7.4. Knee
    • 7.4.1. Global Joint Pain Injections Market, by Knee, By Region, 2019-2032 (USD Billion)
  • 7.5. Shoulder and Elbow
    • 7.5.1. Global Joint Pain Injections Market, by Shoulder and Elbow, By Region, 2019-2032 (USD Billion)
  • 7.6. Hand and Wrist
    • 7.6.1. Global Joint Pain Injections Market, by Hand and Wrist, By Region, 2019-2032 (USD Billion)
  • 7.7. Others
    • 7.7.1. Global Joint Pain Injections Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Joint Pain Injections Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 8.3. Joint Pain Injections Market - North America
    • 8.3.1. North America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.3.2. North America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.3.3. North America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.4. Joint Pain Injections Market - U.S.
      • 8.3.4.1. U.S.: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.3.4.2. U.S.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.3.4.3. U.S.: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.3.5. Joint Pain Injections Market - Canada
      • 8.3.5.1. Canada: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.3.5.2. Canada.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.3.5.3. Canada: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.4. Joint Pain Injections Market - Europe
    • 8.4.1. Europe: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.4.2. Europe.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.4.3. Europe: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.4. Joint Pain Injections Market - UK
      • 8.4.4.1. UK: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.4.2. UK.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.4.3. UK: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.5. Joint Pain Injections Market - France
      • 8.4.5.1. France: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.5.2. France.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.5.3. France: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.6. Joint Pain Injections Market - Germany
      • 8.4.6.1. Germany: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.6.2. Germany.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.6.3. Germany: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.7. Joint Pain Injections Market - Italy
      • 8.4.7.1. Italy: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.7.2. Italy.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.7.3. Italy: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.8. Joint Pain Injections Market - Spain
      • 8.4.8.1. Spain: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.8.2. Spain.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.8.3. Spain: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.9. Joint Pain Injections Market - Netherlands
      • 8.4.9.1. Netherlands: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.9.2. Netherlands.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.9.3. Netherlands: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.4.10. Joint Pain Injections Market - Russia
      • 8.4.10.1. Russia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.4.10.2. Russia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.4.10.3. Russia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.5. Joint Pain Injections Market - Asia Pacific
    • 8.5.1. Asia Pacific: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.5.2. Asia Pacific.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.5.3. Asia Pacific: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.4. Joint Pain Injections Market - China
      • 8.5.4.1. China: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.4.2. China.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.4.3. China: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.5. Joint Pain Injections Market - India
      • 8.5.5.1. India: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.5.2. India.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.5.3. India: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.6. Joint Pain Injections Market - Malaysia
      • 8.5.6.1. Malaysia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.6.2. Malaysia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.6.3. Malaysia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.7. Joint Pain Injections Market - Japan
      • 8.5.7.1. Japan: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.7.2. Japan.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.7.3. Japan: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.8. Joint Pain Injections Market - Indonesia
      • 8.5.8.1. Indonesia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.8.2. Indonesia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.8.3. Indonesia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.5.9. Joint Pain Injections Market - South Korea
      • 8.5.9.1. South Korea: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.5.9.2. South Korea.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.5.9.3. South Korea: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.6. Joint Pain Injections Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.6.2. Middle East & Africa.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.6.3. Middle East & Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.4. Joint Pain Injections Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.4.2. Saudi Arabia.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.5. Joint Pain Injections Market - UAE
      • 8.6.5.1. UAE: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.5.2. UAE.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.5.3. UAE: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.6. Joint Pain Injections Market - Israel
      • 8.6.6.1. Israel: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.6.2. Israel.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.6.3. Israel: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.6.7. Joint Pain Injections Market - South Africa
      • 8.6.7.1. South Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.6.7.2. South Africa.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.6.7.3. South Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.7. Joint Pain Injections Market - Latin America
    • 8.7.1. Latin America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
    • 8.7.2. Latin America.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
    • 8.7.3. Latin America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.4. Joint Pain Injections Market - Mexico
      • 8.7.4.1. Mexico: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.4.2. Mexico.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.4.3. Mexico: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.5. Joint Pain Injections Market - Brazil
      • 8.7.5.1. Brazil: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.5.2. Brazil.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.5.3. Brazil: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 8.7.6. Joint Pain Injections Market - Argentina
      • 8.7.6.1. Argentina: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
      • 8.7.6.2. Argentina.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
      • 8.7.6.3. Argentina: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie Inc
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Alkem Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Anika Therapeutics
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bioventus
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eli Lilly and Company
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Ferring Pharmaceuticals
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. GlaxoSmithKline (GSK)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Johnson & Johnson
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Merck
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Pacira BioSciences, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Pfizer
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Sanofi
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Seikagaku Corporation
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Teva Pharmaceuticals
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Zimmer Biomet
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development

List of Tables

  • Table 1 Global Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 2 Global Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 3 Global Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 4 Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Table 5 North America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 6 North America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 7 North America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 8 U.S.: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 9 U.S.: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 10 U.S.: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 11 Canada: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 12 Canada: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 13 Canada: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 14 Europe: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 15 Europe: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Europe: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 17 UK: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 18 UK: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 19 UK: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 20 France: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 21 France: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 22 France: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 23 Germany: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 24 Germany: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 25 Germany: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 26 Italy: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 27 Italy: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 28 Italy: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 29 Spain: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 30 Spain: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 Spain: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 32 Netherlands: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 33 Netherlands: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 34 Netherlands: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 35 Russia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 36 Russia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 37 Russia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 38 Asia Pacific: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 39 Asia Pacific: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 40 Asia Pacific: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 41 China: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 42 China: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 43 China: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 44 India: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 45 India: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 India: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 47 Malaysia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 48 Malaysia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 49 Malaysia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 50 Japan: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 51 Japan: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 52 Japan: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 53 Indonesia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 54 Indonesia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 55 Indonesia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 56 South Korea: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 57 South Korea: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 58 South Korea: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 59 Middle East & Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 60 Middle East & Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Middle East & Africa: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 62 Saudi Arabia: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 63 Saudi Arabia: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 64 Saudi Arabia: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 65 UAE: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 66 UAE: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 67 UAE: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 68 Israel: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 69 Israel: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 70 Israel: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 71 South Africa: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 72 South Africa: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 73 South Africa: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 74 Latin America: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 75 Latin America: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 Latin America: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 77 Mexico: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 78 Mexico: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 79 Mexico: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 80 Brazil: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 81 Brazil: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 82 Brazil: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)
  • Table 83 Argentina: Joint Pain Injections Market, by Product, 2019-2032 (USD Billion)
  • Table 84 Argentina: Joint Pain Injections Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 85 Argentina: Joint Pain Injections Market, by Joint Type, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Joint Pain Injections Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Distribution Channel
  • Figure 7. Global Joint Pain Injections Market, by Distribution Channel, 2022 & 2032 (USD Billion)
  • Figure 8. Market by Product
  • Figure 9. Global Joint Pain Injections Market, by Product, 2022 & 2032 (USD Billion)
  • Figure 10. Market by Joint Type
  • Figure 11. Global Joint Pain Injections Market, by Joint Type, 2022 & 2032 (USD Billion)
  • Figure 12. Joint Pain Injections Market Assessment, By Geography, 2019-2032 (USD Billion)
  • Figure 13. Strategic Analysis - Joint Pain Injections Market